Replies to post #545569 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Yes, the Keytruda study is the P1 and is for rGBM.

The trial cited below the P1 graph completed all three phases.



This is the completed P3 for murcidencel:

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847